Pharmaceutical Injection

Genotropin is a recombinant human growth hormone (somatropin) developed by Pfizer. It is used to treat growth hormone deficiencies in both children and adults, as well as certain other growth-related conditions.

 Follistatin-315 is a naturally occurring activin and myostatin binding protein. It improves muscle growth (both hypertrophy and hyperplasia), fights inflammatory responses, and boosts fertility. Follistatin-315 is the most abundant form of the glycoprotein found in blood plasma.

Humatrope is a recombinant human growth hormone (somatropin) used to treat growth hormone deficiencies in children and adults. It is a prescription-only injectable medication manufactured by Eli Lilly and Company.

Victoza is a prescription injectable medication used to manage type 2 diabetes mellitus and help improve blood sugar control. Its active ingredient is liraglutide, a GLP-1 receptor agonist.

GHRP-6 is a peptide that has a wide range of potential benefits. It is commonly used by bodybuilders and athletes to help increase muscle mass and strength. Additionally, GHRP-6 has been shown to help promote healing and recovery from injuries.

Botox is a brand name for onabotulinumtoxinA, a purified form of botulinum toxin type A, which is produced by the bacterium Clostridium botulinum. It is a neurotoxic protein that temporarily relaxes muscles by blocking the release of a chemical messenger called acetylcholine, which is responsible for muscle contraction.

Zepbound is the brand name for tirzepatide, a prescription injectable medication developed by Eli Lilly and Company. It is approved for chronic weight management in adults with obesity or overweight who have weight-related medical conditions.

Magnus Trenbolone Enanthate is an anabolic-androgenic steroid (AAS) produced by Magnus Pharmaceuticals, a well-known underground or semi-licensed lab in the bodybuilding community. It is a long-ester version of trenbolone, one of the most powerful anabolic compounds used by advanced athletes for muscle growth, strength, and physique enhancement.

Mazdutide 10 mg is a high-dose, once-weekly injectable medication being studied for weight management and type 2 diabetes. As a dual agonist, it activates both glucagon-like peptide-1 (GLP-1) and glucagon receptors to reduce appetite and increase energy expenditure. The 10 mg dose was evaluated in a phase 1b trial and showed significant weight loss compared to a placebo over a 16-week period. Mazdutide is a synthetic peptide analogue that acts as a dual agonist for two different receptors: 

• GLP-1 receptor activation: Similar to other GLP-1 agonists, this action helps to promote insulin secretion, suppress appetite, and slow gastric emptying, which leads to lower blood glucose and reduced food intake.
• Glucagon receptor activation: Unlike GLP-1 agonists, mazdutide also activates the glucagon receptor. This increases the body's energy expenditure and improves how the liver processes fat, leading to enhanced weight loss. 

INCRELEX is a solution for injection that contains mecasermin which is a synthetic insulin-like growth factor-1 (IGF 1), which is similar to the IGF 1 made by your body. It is used